Form 4 Tracker
Thomas Malley

Director · 3 filings · Latest: Jun 4, 2026

Kiniksa Pharmaceuticals International, plc
Kura Oncology, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
KNSA
Thomas MalleyDirectorMay 29, 2026
Option Exercise
2,79915,345
KURA
Thomas MalleyDirectorMar 18, 2026
Option Exercise
$3.1210,000$31.2K10,000
KNSA
Malley ThomasAug 14, 2025
Proposed Sale
$33.0978,233$2.6M
KNSA
Malley ThomasAug 13, 2025
Proposed Sale
$33.3250,129$1.7M
KNSA
Malley ThomasAug 12, 2025
Proposed Sale
$32.4049,407$1.6M